{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:58:06Z","timestamp":1793141886158,"version":"4.5.0"},"reference-count":208,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308789\/2022-9"],"award-info":[{"award-number":["308789\/2022-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["309688\/2019-1"],"award-info":[{"award-number":["309688\/2019-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006436","name":"Silpakorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001631","name":"University College Dublin","doi-asserted-by":"publisher","award":["82990-NP\/R27885"],"award-info":[{"award-number":["82990-NP\/R27885"]}],"id":[{"id":"10.13039\/501100001631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bcp.2024.116644","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T13:34:33Z","timestamp":1732109673000},"page":"116644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Metallodrugs: Synthesis, mechanism of action and nanoencapsulation for targeted chemotherapy"],"prefix":"10.1016","volume":"231","author":[{"given":"Jessica A.O.","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelakanta S.","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra G.","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namdev","family":"Dhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adenilson O.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco F.","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.bcp.2024.116644_b0005","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.3390\/ijms25137314","article-title":"Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides\u2014Current Developments in Structure-Activity Relationship","volume":"25","author":"Andr\u00e9s","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116644_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108335","article-title":"Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects","volume":"241","author":"Ansari","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116644_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2024.117234","article-title":"Dichloro-bis(theophylline)-copper(II) complex: Characterization of the physicochemical, computational pharmacokinetics, molecular docking, and cytotoxicity as potential antitumoral medicine","author":"de Oliveira Neto","year":"2024","journal-title":"Polyhedron"},{"key":"10.1016\/j.bcp.2024.116644_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111658","article-title":"Structural, thermal, electronic, vibrational, magnetic, and cytotoxic properties of chloro(glycinato-N,O)(1,10-phenanthroline-N,N\u2032)\u2011copper(II) trihydrate coordination complex","volume":"226","author":"de Oliveira Neto","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bcp.2024.116644_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139757","article-title":"Antitumor neodymium(III) complex with 1,10-phenanthroline and nitrate ligands: A comprehensive experimental-theoretical study, in silico pharmacokinetic and cytotoxic properties","volume":"1321","author":"de Oliveira Neto","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bcp.2024.116644_b0030","first-page":"169","article-title":"Biochemical Mechanistic Pathway of Cell Death Induced by Metal-Based Chemotherapeutic Agents, Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates","author":"Arjmand","year":"2024","journal-title":"Springer"},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/acscentsci.3c01340","article-title":"Metals in cancer research: Beyond platinum metallodrugs","volume":"10","author":"Casini","year":"2024","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0040","first-page":"287","article-title":"Nucleolar Targeting by Platinum: p53-Independent Apoptosis Follows rRNA Inhibition","volume":"12","author":"Peterson","year":"2015","journal-title":"Cell-Cycle Arrest, and DNA Compaction, Molecular Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12964-024-01726-3","article-title":"The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm","volume":"22","author":"Vo","year":"2024","journal-title":"Cell Commun. Signaling"},{"key":"10.1016\/j.bcp.2024.116644_b0050","article-title":"Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides\u2014Current Developments in Structure-Activity Relationship","author":"Curieses Andr\u00e9s","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116644_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102303","article-title":"Beyond mere DNA damage: Recent progress in platinum (IV) anticancer complexes containing multi-functional axial ligands","volume":"74","author":"Deng","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bcp.2024.116644_b0060","series-title":"Metal-Based Prodrugs Activated by Cancer-Specific Stimuli","first-page":"1","author":"Dijkstra","year":"2023"},{"key":"10.1016\/j.bcp.2024.116644_b0065","doi-asserted-by":"crossref","DOI":"10.1021\/acs.cgd.4c01324","article-title":"Structural Design, H-bonding Interactions, Vibrational Properties, Periodic-DFT Calculations, and Antibacterial Activity of a Nicotinamide Cocrystal Using Tetradecanoic Acid as Coformer","author":"de Oliveira Neto","year":"2024","journal-title":"Cryst. Growth Des."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chempr.2019.10.013","article-title":"Classification of Metal-based Drugs According to Their Mechanisms of Action","volume":"6","author":"Boros","year":"2020","journal-title":"Chem"},{"issue":"10","key":"10.1016\/j.bcp.2024.116644_b0075","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/biom13101489","article-title":"New Copper-Based Metallodrugs with Anti-Invasive Capacity","volume":"13","author":"Garufi","year":"2023","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0080","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1021\/acs.inorgchem.3c03716","article-title":"Ruthenium pyrazole complexes: a family of highly active metallodrugs for photoactivated chemotherapy","volume":"63","author":"Hirahara","year":"2024","journal-title":"Inorg. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0085","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.3390\/ijms24044076","article-title":"Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models","volume":"24","author":"Ho\u0142ota","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116644_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102276","article-title":"Supramolecular platinum complexes for cancer therapy","volume":"73","author":"Jogadi","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bcp.2024.116644_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.100935","article-title":"Synthesis, biological and medicinal impacts of metallodrugs: A study","volume":"5","author":"Kabir","year":"2023","journal-title":"Results Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/pharmaceutics15020682","article-title":"Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum (II) and Palladium (II) Complexes","volume":"15","author":"Kazimir","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2024.116644_b0105","doi-asserted-by":"crossref","first-page":"1428502","DOI":"10.3389\/fchem.2024.1428502","article-title":"Metallodrugs in cancer therapy: past, present and new strategies","volume":"12","author":"Kostova","year":"2024","journal-title":"Front. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0110","first-page":"393","article-title":"A Comprehensive Review on Metallodrugs in Breast Cancer Treatment, Ceylon Journal of","volume":"52","author":"Kumbhare","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116644_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2023.121816","article-title":"Insights into molecular mechanisms of metallodrugs using metallomic studies","volume":"560","author":"La Manna","year":"2024","journal-title":"Inorg. Chim. Acta"},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0120","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/molecules29081800","article-title":"Dendritic Pyridine\u2013Imine Copper Complexes as Metallo-Drugs","volume":"29","author":"Laurent","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2024.116644_b0125","doi-asserted-by":"crossref","first-page":"e202400120","DOI":"10.1002\/cmdc.202400120","article-title":"Mitochondria\u2010Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes","author":"Li","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bcp.2024.116644_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215366","article-title":"Biomedical applications of multinuclear Pt (II)\/Ru (II)\/Ir (III) metallo-supramolecular assemblies for intensive cancer therapy","volume":"495","author":"Li","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bcp.2024.116644_b0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/9781394209866.ch8","article-title":"Advances in Metallodrug\u2010driven Combination Therapy for Treatment of Cancer","author":"Malviya","year":"2023","journal-title":"Multi\u2010drug Resistance in Cancer"},{"key":"10.1016\/j.bcp.2024.116644_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215026","article-title":"Metallodrug binding to serum albumin: Lessons from biophysical and structural studies","volume":"480","author":"Merlino","year":"2023","journal-title":"Coord. Chem. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00280-015-2901-x","article-title":"Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy","volume":"77","author":"Perego","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116644_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215507","article-title":"Beyond cisplatin: New frontiers in metallodrugs for hard-to-treat triple negative breast cancer","volume":"499","author":"Muhammad","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bcp.2024.116644_b0155","article-title":"Mitochondria-targeted metallo-drugs against cancer: a current mechanistic perspective, Results","author":"Pal","year":"2023","journal-title":"Chemistry"},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2024.116644_b0165","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/nano13101619","article-title":"Platinum-based nanoformulations for glioblastoma treatment: the resurgence of platinum drugs?","volume":"13","author":"Alfonso-Triguero","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bcp.2024.116644_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110834","article-title":"Enhanced potency of a chloro-substituted polyaromatic platinum (II) complex and its platinum (IV) prodrug against lung cancer","volume":"388","author":"Baz","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.bcp.2024.116644_b0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/02603594.2022.2152016","article-title":"Is the next cisplatin already in our laboratory?","volume":"43","author":"Cirri","year":"2023","journal-title":"Comments Inorg. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2024.116644_b0180","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/pharmaceutics15030941","article-title":"Platinum-Nucleos (t) ide Compounds as Possible Antimetabolites for Antitumor\/Antiviral Therapy: Properties and Perspectives","volume":"15","author":"De Castro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2024.116644_b0185","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c00589","article-title":"Oxygen-dependent interactions between the ruthenium cage and the photoreleased inhibitor in NAMPT-targeted photoactivated chemotherapy","author":"Abyar","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116644_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215169","article-title":"An overview of advancement of organoruthenium (II) complexes as prospective anticancer agents","volume":"487","author":"Bashir","year":"2023","journal-title":"Coord. Chem. Rev."},{"issue":"19","key":"10.1016\/j.bcp.2024.116644_b0195","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1039\/D4DT00834K","article-title":"A detailed density functional theory exploration of the photodissociation mechanism of ruthenium complexes for photoactivated chemotherapy","volume":"53","author":"Belletto","year":"2024","journal-title":"Dalton Trans."},{"issue":"6","key":"10.1016\/j.bcp.2024.116644_b0200","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/pharmaceutics15061731","article-title":"New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential","volume":"15","author":"Br\u00e1s","year":"2023","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.bcp.2024.116644_b0205","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/ph16121729","article-title":"Complexes of ruthenium (II) as promising dual-active agents against cancer and viral infections","volume":"16","author":"D\u2019Amato","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2024.116644_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112486","article-title":"Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium (II) metallodrugs in breast cancer therapy","volume":"253","author":"Dom\u00ednguez-Jurado","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bcp.2024.116644_b0215","first-page":"73","article-title":"Interaction Studies of Metal-Based Anticancer Drug Entities with Potential Therapeutic Targets, Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates","author":"Arjmand","year":"2024","journal-title":"Springer"},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0220","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1021\/acsomega.8b01352","article-title":"Efficient Gold(I) Acyclic Diaminocarbenes for the Synthesis of Propargylamines and Indolizines","volume":"3","author":"Aliaga-Lavrijsen","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bcp.2024.116644_b0225","doi-asserted-by":"crossref","first-page":"1338630","DOI":"10.3389\/fchbi.2024.1338630","article-title":"Conjugation of an anti-metabolite nucleobase analogue with a mitochondriotropic agent via palladium (II) against breast cancer cells","volume":"3","author":"Banti","year":"2024","journal-title":"Frontiers in Chemical Biology"},{"issue":"9","key":"10.1016\/j.bcp.2024.116644_b0230","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.3390\/app13095561","article-title":"Recent Advances in Bioconjugated Transition Metal Complexes for Cancer Therapy","volume":"13","author":"Bortolamiol","year":"2023","journal-title":"Appl. Sci."},{"issue":"17","key":"10.1016\/j.bcp.2024.116644_b0235","doi-asserted-by":"crossref","first-page":"e202300178","DOI":"10.1002\/cbic.202300178","article-title":"Exploring the Potential of Metal\u2010Based Candidate Drugs as Modulators of the Cytoskeleton","volume":"24","author":"Borutzki","year":"2023","journal-title":"Chembiochem"},{"key":"10.1016\/j.bcp.2024.116644_b0240","doi-asserted-by":"crossref","unstructured":"A.L. de Andrade Querino, A.M. de Sousa, S.R. Thomas, G.M. de Lima, D. Dittz, A. Casini, R.L. do Monte-Neto, H. Silva, Organogold (III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs, Journal of Inorganic Biochemistry 247 (2023) 112346.","DOI":"10.1016\/j.jinorgbio.2023.112346"},{"issue":"10","key":"10.1016\/j.bcp.2024.116644_b0245","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/inorganics11100394","article-title":"The importance of being Casiopeina as polypharmacologycal profile (mixed chelate\u2013copper (II) complexes and their in vitro and in vivo activities)","volume":"11","author":"Aguilar-Jim\u00e9nez","year":"2023","journal-title":"Inorganics"},{"key":"10.1016\/j.bcp.2024.116644_b0250","first-page":"203","article-title":"Combination Drug Strategies for Targeting Specific Biochemical Pathways for Superior Therapeutic Potency, Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates","author":"Arjmand","year":"2024","journal-title":"Springer"},{"key":"10.1016\/j.bcp.2024.116644_b0255","first-page":"259","article-title":"Progress and Future Projections in Metal-Based Polymeric Anticancer Compounds, Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates","author":"Arjmand","year":"2024","journal-title":"Springer"},{"key":"10.1016\/j.bcp.2024.116644_b0260","first-page":"35","article-title":"Classification of Metal-Based Anticancer Chemotherapeutic Agents, Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates","author":"Arjmand","year":"2024","journal-title":"Springer"},{"issue":"3","key":"10.1016\/j.bcp.2024.116644_b0265","doi-asserted-by":"crossref","first-page":"e202200247","DOI":"10.1002\/tcr.202200247","article-title":"Progress of Metal\u2010Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA\/RNA Binding, Cleavage and Cytotoxicity Activity) Studies","volume":"23","author":"Arjmand","year":"2023","journal-title":"Chem. Rec."},{"issue":"10200","key":"10.1016\/j.bcp.2024.116644_b0270","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(19)31774-X","article-title":"Antibody\u2013drug conjugates for cancer","volume":"394","author":"Chau","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2024.116644_b0275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody\u2013drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.bcp.2024.116644_b0280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/ph13090245","article-title":"Antibody\u2013drug conjugates: The last decade","volume":"13","author":"Joubert","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.bcp.2024.116644_b0285","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/biomedicines9050504","article-title":"Strategies for the improvement of metal-based chemotherapeutic treatments","volume":"9","author":"Cirri","year":"2021","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.bcp.2024.116644_b0290","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/inorganics7070088","article-title":"Unconventional anticancer metallodrugs and strategies to improve their pharmacological profile","volume":"7","author":"Contel","year":"2019","journal-title":"Inorganics"},{"issue":"29","key":"10.1016\/j.bcp.2024.116644_b0295","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.2174\/0929867311209024995","article-title":"From metallodrugs to metallodendrimers for nanotherapy in oncology: a concise overview","volume":"19","author":"El Kazzouli","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/revic-2023-0007","article-title":"Homo and heterometallic ruthenium and platinum complexes with multiple targets for therapeutic applications: a review","volume":"44","author":"De","year":"2024","journal-title":"Rev. Inorg. Chem."},{"key":"10.1016\/j.bcp.2024.116644_b0305","doi-asserted-by":"crossref","DOI":"10.1039\/D3CB00087G","article-title":"Unlocking the potential of platinum drugs: organelle-targeted small-molecule platinum complexes for improved anticancer performance","author":"Deng","year":"2023","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.bcp.2024.116644_b0310","series-title":"Mitochondria as a Metallo-Drug Target for Therapeutic Purposes","first-page":"67","author":"Erxleben","year":"2023"},{"key":"10.1016\/j.bcp.2024.116644_b0315","first-page":"1","article-title":"Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours","author":"Fu","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"15","key":"10.1016\/j.bcp.2024.116644_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26154389","article-title":"Ruthenium Complexes as Promising Candidates against Lung Cancer","volume":"26","author":"Sun","year":"2021","journal-title":"Molecules"},{"issue":"50","key":"10.1016\/j.bcp.2024.116644_b0325","doi-asserted-by":"crossref","first-page":"20745","DOI":"10.1021\/acs.inorgchem.3c02245","article-title":"Radiometal-Labeled Photoactivatable Pt (IV) Anticancer Complex for Theranostic Phototherapy","volume":"62","author":"Imberti","year":"2023","journal-title":"Inorg. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2024.116644_b0330","doi-asserted-by":"crossref","first-page":"e202302948","DOI":"10.1002\/chem.202302948","article-title":"Development of platinum complexes for tumor chemoimmunotherapy, Chemistry\u2013A","volume":"30","author":"Jin","year":"2024","journal-title":"European Journal"},{"key":"10.1016\/j.bcp.2024.116644_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.124035","article-title":"A de novo nanoplatform for the delivery of metal-based drugs studied with high-resolution ICP-MS","volume":"253","author":"Kuznetsova","year":"2023","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/j.bcp.2024.116644_b0340","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3390\/molecules29051066","article-title":"Recently Reported Biological Activities and Action Targets of Pt (II)-and Cu (II)-Based Complexes","volume":"29","author":"Maciel-Flores","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2024.116644_b0345","article-title":"Iminoamido chelated iridium (III) and ruthenium (II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistance","volume":"112631","author":"Guo","year":"2024","journal-title":"J. Inorg. Biochem."},{"issue":"9","key":"10.1016\/j.bcp.2024.116644_b0350","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.3390\/molecules28093969","article-title":"Mechanistic studies of arene\u2013ruthenium (II) complexes with carbothioamidopyrazoles as alternative cancer drugs","volume":"28","author":"Hikisz","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2024.116644_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112195","article-title":"Immunostimulation with chemotherapy of a ruthenium-arene complex via blockading CD47 signal in chronic myelogenous leukemia cells","volume":"243","author":"Hu","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bcp.2024.116644_b0360","doi-asserted-by":"crossref","unstructured":"R. Kanaoujiya, S. Srivastava, R. Singh, G. Mustafa, Recent advances and application of ruthenium complexes in tumor malignancy, Materials Today: Proceedings 72 (2023) 2822-2827.","DOI":"10.1016\/j.matpr.2022.07.098"},{"key":"10.1016\/j.bcp.2024.116644_b0365","article-title":"Unveiling the anticancer activity of ruthenium and iron complexes","volume":"112512","author":"Kannan","year":"2024","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bcp.2024.116644_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.112057","article-title":"Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents","volume":"238","author":"Lv","year":"2023","journal-title":"J. Inorg. Biochem."},{"issue":"12","key":"10.1016\/j.bcp.2024.116644_b0375","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1021\/acs.biomac.3c00949","article-title":"Red-Light-Responsive Polypeptoid Nanoassemblies Containing a Ruthenium (II) Polypyridyl Complex with Synergistically Enhanced Drug Release and ROS Generation for Anticancer Phototherapy","volume":"24","author":"Ma","year":"2023","journal-title":"Biomacromolecules"},{"issue":"28","key":"10.1016\/j.bcp.2024.116644_b0380","doi-asserted-by":"crossref","first-page":"e202400268","DOI":"10.1002\/chem.202400268","article-title":"Not All Binding Sites Are Equal: Site Determination and Folding State Analysis of Gas\u2010Phase Protein\u2010Metallodrug Adducts, Chemistry\u2013A","volume":"30","author":"Eade","year":"2024","journal-title":"European Journal"},{"issue":"9","key":"10.1016\/j.bcp.2024.116644_b0385","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/acs.accounts.3c00037","article-title":"Modulating the chemical reactivity of gold complexes in living systems: from concept to biomedical applications","volume":"56","author":"Jiang","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00280-023-04548-1","article-title":"A biscarbene gold (I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis","volume":"92","author":"K\u00f6nig","year":"2023","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0395","doi-asserted-by":"crossref","first-page":"16706","DOI":"10.1038\/s41598-023-43103-z","article-title":"Mercuric-sulphide based metallopharmaceutical formulation as an alternative therapeutic to combat viral and multidrug-resistant (MDR) bacterial infections","volume":"13","author":"Malarvizhi","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2024.116644_b0400","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/0929867328666211117094550","article-title":"Copper complexes as antitumor agents: In vitro and in vivo evidence","volume":"30","author":"Balsa","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0405","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00775-024-02048-y","article-title":"Silver ciprofloxacin (CIPAG): a multitargeted metallodrug in the development of breast cancer therapy","volume":"29","author":"Banti","year":"2024","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.bcp.2024.116644_b0410","unstructured":"A.M.D.C. Ferreira, E.G. Vieira, R.E.F. de Paiva, R. Miguel, F.F.d.M.B. Franco, C.C. Oliveira, F. Tuna, A.A. Oliveira, An engineered POSS drug delivery system for copper (II) anticancer metallodrugs in selective application toward melanoma cells, Dalton Transactions (2024)."},{"issue":"7","key":"10.1016\/j.bcp.2024.116644_b0415","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.drudis.2013.11.004","article-title":"Antibody\u2013drug conjugates: current status and future directions","volume":"19","author":"Perez","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0420","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2174\/156800909790192365","article-title":"Antibody-drug conjugate targets","volume":"9","author":"Teicher","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"issue":"6","key":"10.1016\/j.bcp.2024.116644_b0425","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1568009622666220224110538","article-title":"Antibody-drug conjugate targets, drugs, and linkers","volume":"22","author":"Teicher","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2024.116644_b0430","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ccr.2019.02.015","article-title":"Recent advances in metallodrug-like molecules targeting non-coding RNAs in cancer chemotherapy","volume":"387","author":"Arjmand","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bcp.2024.116644_b0435","first-page":"1","article-title":"Nanomedicines in the treatment of colon cancer: A focus on metallodrugs","author":"Farinha","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0440","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1574892816666210907101146","article-title":"Metallodrugs as anticancer chemotherapeutics and diagnostic agents: A critical patent review (2010-2020)","volume":"17","author":"Fotopoulou","year":"2022","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"5","key":"10.1016\/j.bcp.2024.116644_b0445","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/2211-5463.13381","article-title":"Metallodrugs: an approach against invasion and metastasis in cancer treatment","volume":"12","author":"Gonz\u00e1lez-Ballesteros","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bcp.2024.116644_b0450","series-title":"Metallodrug-driven combination chemotherapy in cancer treatment","first-page":"95","author":"Hussain","year":"2020"},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0455","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.bcp.2024.116644_b0460","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/156802612799078964","article-title":"Next-generation anticancer metallodrugs","volume":"12","author":"Komeda","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"issue":"35","key":"10.1016\/j.bcp.2024.116644_b0465","doi-asserted-by":"crossref","first-page":"8891","DOI":"10.1002\/chem.202100438","article-title":"Exploring the potential of metallodrugs as chemotherapeutics for triple negative breast cancer, Chemistry\u2013A","volume":"27","author":"Nayeem","year":"2021","journal-title":"European Journal"},{"issue":"7","key":"10.1016\/j.bcp.2024.116644_b0470","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1039\/D1CS00468A","article-title":"Metallodrugs in cancer nanomedicine","volume":"51","author":"Pe\u00f1a","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0475","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2174\/0929867324666171116125908","article-title":"Metallodrugs in targeted cancer therapeutics: aiming at chemoresistance-related patterns and immunosuppressive tumor networks","volume":"26","author":"Petanidis","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0480","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.3390\/pharmaceutics15082044","article-title":"Ferrocene-based drugs, delivery nanomaterials and fenton mechanism: state of the art, recent developments and prospects","volume":"15","author":"Ornelas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"22","key":"10.1016\/j.bcp.2024.116644_b0485","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2174\/1381612829666230809094251","article-title":"From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt Drugs","volume":"29","author":"Akitsu","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2024.116644_b0490","unstructured":"H. Wang, Developing Novel Drug Delivery Systems For Platinum-based Anticancer Drugs Using Coordination-driven Self-assembly, Kent State University, PhD Thesis, College of Arts and Sciences \/ Department of Chemistry and Biochemistry., (2020)."},{"key":"10.1016\/j.bcp.2024.116644_b0495","article-title":"Investigating the role of NEIL3 in colorectal cancer resistance to oxaliplatin, University of Salford (United Kingdom)","volume":"29336371","author":"Iwakun","year":"2021","journal-title":"PhD Thesis"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116644_b0500","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/00958972.2022.2039916","article-title":"Study on a Ru (III) complex containing picolinate with potent inhibition effect against melanoma cell line","volume":"75","author":"Abdolmaleki","year":"2022","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.bcp.2024.116644_b0505","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fonc.2020.00141","article-title":"Combination of ruthenium complex and doxorubicin synergistically inhibits cancer cell growth by down-regulating PI3K\/AKT signaling pathway","volume":"10","author":"Lin","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0510","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/inorganics12010029","article-title":"Survey of Main Group Metals and Metalloids in Cancer Treatment","volume":"12","author":"Kostova","year":"2024","journal-title":"Inorganics"},{"key":"10.1016\/j.bcp.2024.116644_b0515","article-title":"Ferrocene-derived Heterobimetallic Supramolecular Architectures: Synthesis","author":"Tremlett","year":"2022","journal-title":"Guest Encapsulation and Stimulus-Responsive Studies"},{"issue":"19","key":"10.1016\/j.bcp.2024.116644_b0520","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.3390\/molecules27196485","article-title":"Metallo-drugs in cancer therapy: Past, present and future","volume":"27","author":"Lucaciu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2024.116644_b0525","doi-asserted-by":"crossref","unstructured":"P. Mu, Y. Xu, Z. Wang, M. Sjostrom, S. Deng, C. Wang, N. Jonhson, J. Gonzalez, X. Li, L. Metang, ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers, bioRxiv (2023) 2023-10.","DOI":"10.1158\/1538-7445.AM2024-5878"},{"key":"10.1016\/j.bcp.2024.116644_b0530","doi-asserted-by":"crossref","first-page":"1278157","DOI":"10.3389\/fonc.2023.1278157","article-title":"Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma","volume":"13","author":"Al-Gizawiy","year":"2024","journal-title":"Front. Oncol."},{"issue":"48","key":"10.1016\/j.bcp.2024.116644_b0535","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bcp.2024.116644_b0540","doi-asserted-by":"crossref","unstructured":"V. Uivarosi, A.-C. Munteanu, M. Badea, R. Olar, Metal Complexes of Plant Secondary Metabolites with Therapeutic Potential, Plant Secondary Metabolites: Physico-Chemical Properties and Therapeutic Applications, Springer2022, pp. 281-327.","DOI":"10.1007\/978-981-16-4779-6_9"},{"key":"10.1016\/j.bcp.2024.116644_b0545","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccr.2015.11.004","article-title":"New trends in platinum and palladium complexes as antineoplastic agents","volume":"310","author":"Fanelli","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bcp.2024.116644_b0550","article-title":"Nano pharmaceutical delivery in combating colorectal cancer","volume":"100173","author":"Singh","year":"2023","journal-title":"Med. Drug Discovery"},{"key":"10.1016\/j.bcp.2024.116644_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132481","article-title":"EGCG-vanadium nanomedicine with neutral pH Fenton reaction activity inhibits heat shock proteins for enhanced photothermal\/chemodynamic therapy","volume":"271","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2024.116644_b0560","doi-asserted-by":"crossref","unstructured":"S.K. Vechalapu, R. Kumar, N. Chatterjee, S. Gupta, S. Khanna, P.Y. Thimmappa, S. Senthil, R. Eerlapally, M.B. Joshi, S.K. Misra, A. Draksharapu, D. Allimuthu, Redox modulator iron complexes trigger intrinsic apoptosis pathway in cancer cells, iScience 27(6) (2024).","DOI":"10.1016\/j.isci.2024.109899"},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0565","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/inorganics12010026","article-title":"Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer Application","volume":"12","author":"Claudio-Ares","year":"2024","journal-title":"Inorganics"},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0570","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41598-024-56339-0","article-title":"Synthesis, anticancer activity, and molecular docking of half-sandwich iron (II) cyclopentadienyl complexes with maleimide and phosphine or phosphite ligands","volume":"14","author":"Das","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116644_b0575","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c00641","article-title":"1, 3, 5-Triaza-7-phosphaadamantane and Cyclohexyl Groups Impart to Di-Iron (I) Complex Aqueous Solubility and Stability, and Prominent Anticancer Activity in Cellular and Animal Models","author":"De Franco","year":"2024","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2024.116644_b0580","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.3390\/ijms25074011","article-title":"Zinc (II) Iminopyridine Complexes as Antibacterial Agents: A Structure-to-Activity Study","volume":"25","author":"de la Mata Moratilla","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116644_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotochem.2023.114830","article-title":"A new zinc (II) complex of 2-benzoimidazoledisulfide ligand: synthesis, X-ray crystallographic structure, investigation of CT-DNA and BSA interaction by spectroscopic techniques and molecular docking","volume":"443","author":"Mohammadlou","year":"2023","journal-title":"J. Photochem. Photobiol. A Chem."},{"key":"10.1016\/j.bcp.2024.116644_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2023.116622","article-title":"Development of new cobalt, copper, and zinc complexes of Schiff-base ligands as prospective chemotherapeutic agents","volume":"245","author":"Narayanan","year":"2023","journal-title":"Polyhedron"},{"key":"10.1016\/j.bcp.2024.116644_b0595","series-title":"Zinc complexes: Their interaction with nucleic acids and other biomolecular targets","first-page":"1","author":"Yousuf","year":"2023"},{"key":"10.1016\/j.bcp.2024.116644_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122784","article-title":"Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study","volume":"636","author":"Michlewska","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2024.116644_b0605","series-title":"Ruthenium complexes: An insight into their interactions with nucleic acids and biomolecules","first-page":"43","author":"Parveen","year":"2023"},{"issue":"22","key":"10.1016\/j.bcp.2024.116644_b0610","doi-asserted-by":"crossref","first-page":"e202300397","DOI":"10.1002\/cmdc.202300397","article-title":"Recent Advances in Mitochondria\u2010Localized Luminescent Ruthenium (II) Metallodrugs as Anticancer Agents","volume":"18","author":"Patra","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bcp.2024.116644_b0615","article-title":"Half-sandwich Ru (II) N-heterocyclic carbene complexes in anticancer drug design","volume":"245","author":"Rojas","year":"2023","journal-title":"J. Inorg. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0620","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/revic-2023-0010","article-title":"Ruthenium complexes for breast cancer therapy","volume":"44","author":"Sadique","year":"2024","journal-title":"Rev. Inorg. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0625","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1039\/D3DT02941G","article-title":"Hyphenation of lipophilic ruthenium (ii)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells","volume":"53","author":"Saha","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bcp.2024.116644_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2023.100104","article-title":"Metallo-antiviral aspirants: answer to the upcoming virus outbreak","volume":"8","author":"Mehrotra","year":"2023","journal-title":"European Journal of Medicinal Chemistry Reports"},{"issue":"10","key":"10.1016\/j.bcp.2024.116644_b0635","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1021\/acs.chemrev.2c00649","article-title":"Next generation gold drugs and probes: chemistry and biomedical applications","volume":"123","author":"Mertens","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2024.116644_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102235","article-title":"Mitochondria as a target of third row transition metal-based anticancer complexes","volume":"72","author":"Olelewe","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116644_b0645","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.3390\/molecules28093941","article-title":"Graphene as Nanocarrier for Gold (I)-Monocarbene Complexes: Strength and Nature of Physisorption","volume":"28","author":"Orek","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bcp.2024.116644_b0650","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.3390\/ijms24065738","article-title":"New 4, 5-Diarylimidazol-2-ylidene\u2013iodidogold (I) Complexes with High Activity against Esophageal Adenocarcinoma Cells","volume":"24","author":"Schleser","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"29","key":"10.1016\/j.bcp.2024.116644_b0655","doi-asserted-by":"crossref","first-page":"16261","DOI":"10.1021\/jacs.3c05492","article-title":"Metal-mediated, autolytic amide bond cleavage: a strategy for the selective, metal complexation-catalyzed, controlled release of metallodrugs","volume":"145","author":"\u015ami\u0142owicz","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0660","first-page":"141","article-title":"Nano-Organometallic Compounds as Prospective Metal Based Anti-Lung Cancer Drugs: Biochemical and Molecular Docking Studies","volume":"18","author":"Abdou","year":"2023","journal-title":"TWIST"},{"issue":"7","key":"10.1016\/j.bcp.2024.116644_b0665","first-page":"488","article-title":"An Insight into the Effect of Schiff Base and their d and f Block Metal Complexes on Various Cancer Cell Lines as Anticancer Agents","volume":"24","author":"Chaturvedi","year":"2024","journal-title":"A Review, Anti-Cancer Agents in Medicinal Chemistry (formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"issue":"13","key":"10.1016\/j.bcp.2024.116644_b0670","doi-asserted-by":"crossref","first-page":"16343","DOI":"10.1021\/acsami.2c19246","article-title":"A Smart Benzothiazole-Based Conjugated Polymer Nanoplatform with Multistimuli Response for Enhanced Synergistic Chemo-Photothermal Cancer Therapy","volume":"15","author":"Chen","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0675","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1021\/acsanm.3c06195","article-title":"Ameliorating Old Drugs with New Tricks in the Nano Realms","volume":"7","author":"Choudhury","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bcp.2024.116644_b0680","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.actbio.2023.03.017","article-title":"Biomimetic nanoplatform with H2O2 homeostasis disruption and oxidative stress amplification for enhanced chemodynamic therapy","volume":"162","author":"Fu","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2024.116644_b0685","first-page":"239","article-title":"Bioorganometallic chemistry: a new horizon on organometallic landscape, Recent","author":"Hafiz","year":"2024","journal-title":"Adv. Organomet. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0690","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41427-023-00473-0","article-title":"Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-\/immunotherapy","volume":"15","author":"Liu","year":"2023","journal-title":"NPG Asia Mater."},{"issue":"84","key":"10.1016\/j.bcp.2024.116644_b0695","doi-asserted-by":"crossref","first-page":"12548","DOI":"10.1039\/D3CC04286C","article-title":"Progress in controllable bioorthogonal catalysis for prodrug activation","volume":"59","author":"Liu","year":"2023","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2024.116644_b0700","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1039\/D3DT01864D","article-title":"Chromophore appended DPA-based copper (ii) complexes with a diimine motif towards DNA binding and fragmentation studies","volume":"53","author":"Mathur","year":"2024","journal-title":"Dalton Trans."},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0705","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1634\/theoncologist.2017-0041","article-title":"Curative, Life\u2010Extending, and Palliative Chemotherapy: New Outcomes Need New Names","volume":"22","author":"Neugut","year":"2017","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0710","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.bcp.2024.116644_b0715","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2019.02.038","article-title":"Pharmacological effectors of GRP78 chaperone in cancers","volume":"163","author":"Bailly","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116644_b0720","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The Role of Autophagy in Cancer: Therapeutic Implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"19","key":"10.1016\/j.bcp.2024.116644_b0725","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.3390\/cancers14194544","article-title":"Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment","volume":"14","author":"Van Stiphout","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bcp.2024.116644_b0730","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1021\/acs.jproteome.6b00430","article-title":"Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences","volume":"15","author":"Stewart","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bcp.2024.116644_b0735","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchromb.2018.10.017","article-title":"Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer","volume":"1102\u20131103","author":"Sun","year":"2018","journal-title":"J. Chromatogr. B"},{"issue":"13","key":"10.1016\/j.bcp.2024.116644_b0740","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/cbic.202000838","article-title":"DNA-Targeted Metallodrugs: An Untapped Source of Artificial Gene Editing Technology","volume":"22","author":"Fantoni","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.bcp.2024.116644_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111624","article-title":"Covalent and noncovalent interactions of coordination compounds with DNA: An overview","volume":"225","author":"Andrez\u00e1lov\u00e1","year":"2021","journal-title":"J. Inorg. Biochem."},{"issue":"18","key":"10.1016\/j.bcp.2024.116644_b0750","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1093\/nar\/gkab817","article-title":"Click and Cut: a click chemistry approach to developing oxidative DNA damaging agents","volume":"49","author":"McStay","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116644_b0755","article-title":"Understanding Cu+2 binding with DNA: A molecular dynamics study comparing Cu2+ and Mg2+ binding to the Dickerson DNA","volume":"107347","author":"Sharma","year":"2024","journal-title":"Biophys. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0760","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1039\/C8CS00157J","article-title":"Molecular methods for assessment of non-covalent metallodrug\u2013DNA interactions","volume":"48","author":"Kellett","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0765","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/nar\/gkw1097","article-title":"C3-symmetric opioid scaffolds are pH-responsive DNA condensation agents","volume":"45","author":"McStay","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"10.1016\/j.bcp.2024.116644_b0770","doi-asserted-by":"crossref","first-page":"9918","DOI":"10.1093\/nar\/gky806","article-title":"A phosphate-targeted dinuclear Cu(II) complex combining major groove binding and oxidative DNA cleavage","volume":"46","author":"Molphy","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116644_b0775","series-title":"DNA-Targeting Molecules as Therapeutic Agents","first-page":"198","author":"Cardin","year":"2018"},{"key":"10.1016\/j.bcp.2024.116644_b0780","doi-asserted-by":"crossref","unstructured":"K. Tummalapalli, V. C.S, P. Munusami, M. Pathak, B. M.M, Evaluation of DNA\/Protein interactions and cytotoxic studies of copper(II) complexes incorporated with N, N donor ligands and terpyridine ligand, International Journal of Biological Macromolecules 95 (2017) 1254-1266.","DOI":"10.1016\/j.ijbiomac.2016.11.022"},{"issue":"21","key":"10.1016\/j.bcp.2024.116644_b0785","doi-asserted-by":"crossref","first-page":"9502","DOI":"10.1007\/s10853-024-09795-y","article-title":"Synthesis, electronic and vibrational properties, solvation effects, ADME and cytotoxic assay of aqua-(1,10-phenanthroline)-tyrosinato-copper(II) nitrate dihydrate complex: experimental and theoretical studies","volume":"59","author":"Pereira","year":"2024","journal-title":"J. Mater. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2024.116644_b0790","doi-asserted-by":"crossref","first-page":"2300240","DOI":"10.1002\/crat.202300240","article-title":"Structural, Vibrational, Thermal, and Cytotoxic Characterization of Aqua(1,10-Phenanthroline)(L-Serinato)Copper(II) Nitrate Complex Combined with DFT Calculations","volume":"58","author":"Ramos","year":"2023","journal-title":"Cryst Res Technol"},{"key":"10.1016\/j.bcp.2024.116644_b0795","doi-asserted-by":"crossref","unstructured":"P.J. O'Dwyer, J.P. Stevenson, S.W. Johnson, Clinical Status of Cisplatin, Carboplatin, and Other Platinum-Based Antitumor Drugs, in: Cisplatin, B. Lippert (Ed.). pp. 29-69, https:\/\/doi.org\/10.1002\/9783906390420.ch2, Cisplatin1999, pp. 29-69.","DOI":"10.1002\/9783906390420.ch2"},{"issue":"5","key":"10.1016\/j.bcp.2024.116644_b0800","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jinorgbio.2005.02.020","article-title":"Copper(II) complexes of 1,10-phenanthroline-derived ligands: Studies on DNA binding properties and nuclease activity","volume":"99","author":"Hirohama","year":"2005","journal-title":"J. Inorg. Biochem."},{"issue":"3","key":"10.1016\/j.bcp.2024.116644_b0805","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cbi.2006.12.002","article-title":"Mixed chelate copper complex, Casiopeina IIgly\u00ae, binds and degrades nucleic acids: A mechanism of cytotoxicity","volume":"165","author":"Rivero-M\u00fcller","year":"2007","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.bcp.2024.116644_b0810","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.freeradbiomed.2012.05.034","article-title":"Radical-induced DNA damage by cytotoxic square-planar copper(II) complexes incorporating o-phthalate and 1,10-phenanthroline or 2,2\u2032-dipyridyl","volume":"53","author":"Kellett","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2024.116644_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214307","article-title":"Latest developments in metal complexes as anticancer agents","volume":"452","author":"Paprocka","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bcp.2024.116644_b0820","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1242488","article-title":"Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes","volume":"14","author":"Xu","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0825","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1038\/s41598-019-41063-x","article-title":"Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies","volume":"9","author":"Hussain","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2024.116644_b0830","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1021\/acs.jmedchem.0c00431","article-title":"Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies","volume":"63","author":"Notaro","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116644_b0835","doi-asserted-by":"crossref","unstructured":"J.A.O. Rodrigues, J.G.d. Oliveira Neto, A.O. da Silva de Barros, A.P. Ayala, R. Santos-Oliveira, A.S. de Menezes, F.F. de Sousa, Copper(II):phenanthroline complexes with l-asparagine and l-methionine: Synthesis, crystal structure and in-vitro cytotoxic effects on prostate, breast and melanoma cancer cells, Polyhedron 191 (2020) 114807.","DOI":"10.1016\/j.poly.2020.114807"},{"issue":"3","key":"10.1016\/j.bcp.2024.116644_b0840","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/14756366.2011.588950","article-title":"Antiproliferative effects of metal complexes of new isatin hydrazones against HCT116, MCF7 and HELA tumour cell lines","volume":"27","author":"Kandile","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0845","article-title":"Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition","volume":"11","author":"Richard","year":"2015","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.bcp.2024.116644_b0850","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.saa.2014.05.050","article-title":"Synthesis and characterization of metal complexes of Schiff base ligand derived from imidazole-2-carboxaldehyde and 4-aminoantipyrine","volume":"133","author":"Selwin Joseyphus","year":"2014","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"11","key":"10.1016\/j.bcp.2024.116644_b0855","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1021\/jm5005946","article-title":"Luminescent Ruthenium Complexes for Theranostic Applications","volume":"57","author":"Cardoso","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0860","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1078-0432.CCR-17-1114","article-title":"Phase Ib\/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors","volume":"24","author":"Subbiah","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116644_b0865","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lungcan.2018.09.014","volume":"125","author":"Kawano","year":"2018","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0870","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1039\/C3SC53243G","article-title":"NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application","volume":"5","author":"Trondl","year":"2014","journal-title":"Chem. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0875","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0b013e328322fbc5","article-title":"E. in collaboration with Central European Society for Anticancer Drug Research, Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study","volume":"20","author":"Lentz","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2024.116644_b0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116211","article-title":"A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies","volume":"171","author":"Adhikari","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0885","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acs.chemrev.8b00211","article-title":"Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433","volume":"119","author":"Monro","year":"2019","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0890","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1186\/s12885-016-2744-9","article-title":"Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo","volume":"16","author":"Harima","year":"2016","journal-title":"BMC Cancer"},{"issue":"16","key":"10.1016\/j.bcp.2024.116644_b0895","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s40265-022-01795-z","article-title":"Darinaparsin: First Approval","volume":"82","author":"Frampton","year":"2022","journal-title":"Drugs"},{"issue":"18","key":"10.1016\/j.bcp.2024.116644_b0900","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2174\/0929867054637626","article-title":"Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches","volume":"12","author":"Galanski Sophia","year":"2005","journal-title":"Curr. Med. Chem."},{"issue":"23","key":"10.1016\/j.bcp.2024.116644_b0905","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.drudis.2009.09.003","article-title":"Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs","volume":"14","author":"van Rijt","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"45","key":"10.1016\/j.bcp.2024.116644_b0910","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1039\/c3cc41143e","article-title":"Exploration of the medical periodic table: towards new targets","volume":"49","author":"Barry","year":"2013","journal-title":"Chem. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0915","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cbpa.2007.11.013","article-title":"New trends for metal complexes with anticancer activity","volume":"12","author":"Bruijnincx","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0920","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1021\/acs.jmedchem.7b01694","article-title":"Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells","volume":"61","author":"Huang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0925","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/jm100020w","article-title":"Organometallic Anticancer Compounds","volume":"54","author":"Gasser","year":"2011","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0930","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1039\/B707077M","article-title":"Bioorganometallic chemistry\u2014from teaching paradigms to medicinal applications","volume":"38","author":"Hartinger","year":"2009","journal-title":"Chem. Soc. Rev."},{"issue":"19","key":"10.1016\/j.bcp.2024.116644_b0935","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1039\/b411910j","article-title":"Deoxyribozymes: DNA catalysts for bioorganic chemistry","volume":"2","author":"Silverman","year":"2004","journal-title":"Org. Biomol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0940","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in Medicinal Inorganic Chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev."},{"issue":"7782","key":"10.1016\/j.bcp.2024.116644_b0945","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2024.116644_b0950","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1124\/dmd.105.004374","article-title":"Cancer chemotherapy and drug metabolism","volume":"33","author":"Riddick","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2024.116644_b0955","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/s41467-021-23071-6","article-title":"Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance","volume":"12","author":"Giddings","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b0960","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1007\/s11033-021-06314-z","article-title":"DNA repair pathways and their roles in drug resistance for lung adenocarcinoma","volume":"48","author":"Kara","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bcp.2024.116644_b0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100743","article-title":"Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance","volume":"54","author":"Wang","year":"2021","journal-title":"Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy"},{"issue":"10","key":"10.1016\/j.bcp.2024.116644_b0970","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2024.116644_b0975","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2022.04.007","article-title":"Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer","volume":"346","author":"Sharma","year":"2022","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.bcp.2024.116644_b0980","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/pon.5997","article-title":"Factors promoting breast, cervical and colorectal cancer screenings participation: A systematic review","volume":"31","author":"Vallone","year":"2022","journal-title":"Psychooncology"},{"issue":"13","key":"10.1016\/j.bcp.2024.116644_b0985","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/cncr.32859","article-title":"Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women","volume":"126","author":"Duffy","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b0990","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of Prostate-Specific Antigen","volume":"21","author":"Balk","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116644_b0995","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1002\/mco2.265","article-title":"Understanding and targeting resistance mechanisms in cancer","volume":"4","author":"Lei","year":"2023","journal-title":"MedComm"},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b1000","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040669","article-title":"Drug Combination in Cancer Treatment-From Cocktails to Conjugated Combinations","volume":"13","author":"Gilad","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"40","key":"10.1016\/j.bcp.2024.116644_b1005","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc7828","article-title":"An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug\/gene delivery nanoparticles","volume":"6","author":"Wu","year":"2020","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.bcp.2024.116644_b1010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071614","article-title":"Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression","volume":"14","author":"Fontana","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bcp.2024.116644_b1015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/17425247.2020.1737672","article-title":"The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis","volume":"17","author":"Zahednezhad","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bcp.2024.116644_b1020","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-024-01784-1","article-title":"A cuproptosis nanocapsule for cancer radiotherapy","author":"Liao","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b1025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00775-023-02039-5","article-title":"Lysosome-targeted ruthenium(II) complex encapsulated with pluronic\u00ae F-127 induces oncosis in A549 cells","volume":"29","author":"Pan","year":"2024","journal-title":"J. Biol. Inorg. Chem."},{"issue":"18","key":"10.1016\/j.bcp.2024.116644_b1030","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.3390\/ijms21186928","article-title":"Comparative study of the mode of action of clinically approved platinum-based chemotherapeutics","volume":"21","author":"Schoch","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"58","key":"10.1016\/j.bcp.2024.116644_b1035","doi-asserted-by":"crossref","first-page":"98426","DOI":"10.18632\/oncotarget.21416","article-title":"A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)","volume":"8","author":"Golla","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bcp.2024.116644_b1040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/inorganics8020010","article-title":"Evaluating ligand modifications of the titanocene and auranofin moieties for the development of more potent anticancer drugs","volume":"8","author":"Fernandez-Vega","year":"2020","journal-title":"Inorganics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224006440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224006440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:06:53Z","timestamp":1777399613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224006440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":208,"alternative-id":["S0006295224006440"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116644","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metallodrugs: Synthesis, mechanism of action and nanoencapsulation for targeted chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116644"}}